Keriton, a market leader in innovative cloud-based software that streamlines breast milk and formula management and supports safe feeding practices, announced today that it has been acquired by Natus Sensory, a global leader in sensory and newborn care solutions. Keriton will become part of Natus Sensory’s Newborn Care portfolio, with a continued focus on innovation, clinical collaboration, and customer support.

Scaling our impact on neonatal and pediatric care through innovation

“Joining Natus Sensory marks an exciting next chapter for Keriton, accelerating adoption of our mission critical platform,” said Adam Dakin, CEO of Keriton. “We share an unwavering commitment to improving care for newborns and supporting the clinicians and families who care for them. Natus’ global presence and resources will further enhance our ability to continue providing best in class technology and support for our patients and clinical partners.”

“Keriton is a strong strategic and cultural fit for Natus Sensory,” says Peter Reimer, CEO of Natus Sensory. “Their proven impact on feeding safety and focus on supporting clinical teams in the NICU and pediatric care settings aligns directly with our mission to shape the future of newborn care, where every baby has the best start in life through trusted solutions and clinical expertise. This acquisition strengthens our Newborn Care portfolio and deepens our role as a long-term partner to hospitals and care teams.”

A unified ecosystem for newborn care

The integration of Keriton’s solution with Natus Sensory’s extensive portfolio including hearing screening and vision screening devices, jaundice phototherapy systems, NicView^® video monitoring, and Neometrics^® case management and reporting software and services, will enable hospitals and clinicians to access a more unified ecosystem for newborn care.

Keriton

Keriton is a Philadelphia based technology company focused on improving neonatal and pediatric feeding management through cloud-based software solutions. Its platform supports safer feeding practices, clinical efficiency, and family engagement across NICUs and pediatric care settings. Keriton investors include BioAdvance Capital, Dreamit Ventures, Ben Franklin Technology Partners, and the Broad Street Angels. Home - Keriton

Natus Sensory

Natus Sensory is a global leader in solutions for assessing, fitting and screening in the areas of hearing, balance, vision and newborn care, including hearing screening and vision screening devices, jaundice phototherapy systems, NicView^® video monitoring, and Neometrics^® case management and reporting software and services - making a meaningful difference in patient care. With a legacy of groundbreaking innovation, we are committed to improving outcomes for patients and supporting the daily work of healthcare professionals. At the core of our innovation is a dedication to listening to clinicians, ensuring every product addresses real-world challenges. Our solutions are known for their ease of use, reliability, and safety. Beyond products, Natus Sensory offers comprehensive training and education - empowering clinicians with the knowledge and support they need to deliver exceptional care. Natus Sensory is an ARCHIMED company since 2022. Home - Natus Sensory

ARCHIMED

With offices in Europe, North America and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €9 billion across its various funds. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation. ARCHIMED - Impacting Healthcare

View source version on businesswire.com: https://www.businesswire.com/news/home/20260128468891/en/